Table 2.
The Birmingham IBS Severity Scoring System and its three domains in placebo and FMT‐treated patients
| Time | Group | Total score (mean ± SD) | Pain (mean ± SD) | Diarrhea (mean ± SD) | Constipation (mean ± SD) |
|---|---|---|---|---|---|
| 0 | Placebo | 23.2 ± 8.1 | 7.3 ± 3.3 | 7.8 ± 4.9 | 7.7 ± 3.7 |
| FMT 30 g | 5.9 ± 5.7 | 8.3 ± 2.0 | 10.3 ± 4.2 | 7.3 ± 3.2 | |
| FMT 60 g | 25.7 ± 6.8 | 8.2 ± 2.7 | 9.2 ± 4.9 | 8.3 ± 3.2 | |
| 1 month | Placebo | 21.3 ± 8.2 | 7.2 ± 3.5 | 6.5 ± 4.9 | 7.5 ± 3.2 |
| FMT 30 g | 19.0 ± 8.0**** | 6.0 ± 3.1*** | 6.9 ± 4.7*** | 5.7 ± 3.4* | |
| FMT 60 g | 16.4 ± 8.6**** | 5.1 ± 3.1**** | 5.2 ± 4.0**** | 6.2 ± 4.9** |
* p < 0.05;
** p < 0.01;
*** p 0.001;
**** P < 0.0001 as compared to baseline.